Is Moyamoya hereditary?

Moyamoya disease is considered a complex, multifactorial condition where genetics play a significant role, though it is not strictly hereditary in a simple Mendelian sense for the majority of patients.

Understanding the Genetic Component

While most cases of Moyamoya are sporadic, meaning they occur in individuals with no family history, approximately 10% to 15% of cases are familial. The condition is not caused by a single gene mutation in a classic autosomal dominant or recessive pattern; rather, it is likely the result of a combination of genetic predispositions and environmental triggers. Researchers have identified the RNF213 gene as a major susceptibility factor, particularly in populations of East Asian descent, where variants in this gene are strongly associated with the development of Moyamoya.

Inheritance and Risk Assessment

Because the inheritance is multifactorial, it is difficult to provide a precise percentage risk for the children of an affected parent. When a family member has Moyamoya, the risk to first-degree relatives is higher than that of the general population, but it does not follow the predictable patterns of single-gene disorders. De novo (spontaneous) mutations can occur, but the complexity of the genetic architecture means that recurrence risk is generally considered low, though it should be evaluated on a case-by-case basis by a clinical geneticist.

Genetic Counseling and Testing

Genetic testing for the RNF213 gene is available, but it is not currently used as a standard diagnostic tool for all patients. It is most often recommended in the context of research or for families with a strong history of the disease to clarify risks. We strongly encourage families to engage in genetic counseling, which provides a safe space to discuss the implications of these findings, understand the limitations of current testing, and address concerns regarding family planning. For those navigating Moyamoya, counseling helps distinguish between familial patterns and sporadic occurrences, offering clarity in an otherwise uncertain landscape.

Medical Disclaimer: This information is for educational purposes and should not replace professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD)


• Orphanet: The portal for rare diseases and orphan drugs


• Online Mendelian Inheritance in Man (OMIM)


• Moyamoya Foundation